| scholarly article | Q13442814 |
| P50 | author | Maria Loane | Q28484211 |
| P2093 | author name string | H Dolk | |
| P A Boyd | |||
| B Khoshnood | |||
| EUROCAT Working Group | |||
| E Garne | |||
| C Devigan | |||
| P2860 | cites work | Choice of effect measure for epidemiological data | Q30614196 |
| Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection | Q33268343 | ||
| Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality | Q33751909 | ||
| What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes | Q34154278 | ||
| Antenatal screening for Down's syndrome. | Q40909255 | ||
| Towards informed decisions about prenatal testing: a review | Q40964038 | ||
| Prenatal diagnosis in the Netherlands. Dutch Working Party of Prenatal Diagnosis. | Q41430745 | ||
| Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation | Q43695537 | ||
| First-trimester or second-trimester screening, or both, for Down's syndrome | Q46799629 | ||
| Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe | Q50129012 | ||
| Prenatal diagnosis and selective abortion: a challenge to practice and policy. | Q53536884 | ||
| Prenatal testing: towards realistic expectations of patients, providers and policy makers | Q57745544 | ||
| Attributions for disability: The influence of genetic screening | Q57745696 | ||
| Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality | Q74459714 | ||
| Integrated screening for Down's syndrome based on tests performed during the first and second trimesters | Q78109767 | ||
| First-trimester screening for trisomies 21 and 18 | Q79133560 | ||
| A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study | Q79756571 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 689-696 | |
| P577 | publication date | 2008-05-01 | |
| P1433 | published in | BJOG: an International Journal of Obstetrics and Gynaecology | Q15724571 |
| P1476 | title | Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome | |
| P478 | volume | 115 |
| Q99558214 | 'We are all in the image of God': reproductive imaginaries and prenatal genetic testing in American Jewish communities |
| Q37737743 | A Framework for Describing the Influence of Service Organisation and Delivery on Participation in Fetal Anomaly Screening in England |
| Q36992107 | A cost-of-illness study of spina bifida in Italy. |
| Q39160177 | A population-based study of prevalence of Down syndrome in Southern Thailand |
| Q58801404 | A post-mortem population survey on foetal-infantile end-of-life decisions: a research protocol |
| Q47402045 | A prospective study on fetal posterior cranial fossa assessment for early detection of open spina bifida at 11-13 weeks |
| Q47328775 | Antenatal imaging: does the postnatal impact justify the effort? |
| Q44138720 | Are midwifery clients in Ontario making informed choices about prenatal screening? |
| Q44688214 | Atrioventricular septal defects among infants in Europe: a population-based study of prevalence, associated anomalies, and survival |
| Q34745570 | Birth defects among a cohort of infants born to HIV-infected women on antiretroviral medication |
| Q58741104 | Changes in the Detection and Management of Foetal Trisomies over Time |
| Q45181290 | Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: a population-based evaluation |
| Q38768692 | Comorbidities in Down syndrome livebirths and health care intervention: an initial experience from the birth defects registry in Southern Thailand |
| Q36062209 | Complicated grief after perinatal loss |
| Q42262784 | Confrontation between ultrasound and fetopathological examination following therapeutic abortion performed in a maternity clinic in Tunisia |
| Q40809450 | Continuation of pregnancy despite a diagnosis of severe fetal anomaly: a retrospective French study |
| Q40481402 | Correlation between prenatal ultrasound and postmortem findings in 1029 fetuses following termination of pregnancy. |
| Q53087139 | Counseling parents before prenatal diagnosis: do we need to say more about the sex chromosome aneuploidies? |
| Q37221303 | Daily life changes and adaptations investigated in 154 families with a child suffering from a rare disability at a public centre for rare diseases in Northern Italy. |
| Q22242353 | Decision Making Following a Prenatal Diagnosis of Down Syndrome: An Integrative Review |
| Q39537349 | Decision-making after prenatal diagnosis of a syndrome predisposing to intellectual disability: what prospective parents need to know and the importance of non-medical information |
| Q38101151 | Determinants affecting pregnant women's utilization of prenatal screening for Down syndrome: a review of the literature |
| Q39051403 | Determinants of first trimester combined test participation within the central region of the Netherlands |
| Q47661362 | Documenting moral agency: a qualitative analysis of abortion decision making for fetal indications. |
| Q47546261 | Does the Use of Diagnostic Technology Reduce Fetal Mortality? |
| Q33641024 | EUROCAT website data on prenatal detection rates of congenital anomalies |
| Q26829247 | Epidemiologic tools to study the influence of environmental factors on fecundity and pregnancy-related outcomes |
| Q38203855 | Epidemiology of multiple congenital anomalies in Europe: a EUROCAT population-based registry study |
| Q35183494 | Epidemiology, prenatal management, and prevention of neural tube defects. |
| Q101140306 | Estimation of the number of people with Down syndrome in Europe |
| Q47705554 | Ethnicity and Language Proficiency Differences in the Provision of and Intention to Use Prenatal Screening for Down's Syndrome and Congenital Anomalies. A Prospective, Non-selected, Register-Based Study in the Netherlands |
| Q34677322 | Explaining variation in Down's syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews |
| Q35892933 | Factors associated with utilization of maternal serum screening for Down syndrome in mainland China: a cross-sectional study |
| Q35127381 | False positive morphologic diagnoses at the anomaly scan: marginal or real problem, a population-based cohort study |
| Q30570708 | Fetal cerebral imaging - ultrasound vs. MRI: an update |
| Q52150139 | Fetal diffusion tensor quantification of brainstem pathology in Chiari II malformation. |
| Q90647445 | Fetal profile in fetuses with open spina bifida |
| Q34081367 | Gestational age patterns of fetal and neonatal mortality in Europe: results from the Euro-Peristat project |
| Q52146907 | Global Birth Prevalence of Spina Bifida by Folic Acid Fortification Status: A Systematic Review and Meta-Analysis. |
| Q35529209 | Grief after second-trimester termination for fetal anomaly: a qualitative study |
| Q48352229 | Has noninvasive prenatal testing impacted termination of pregnancy and live birth rates of infants with Down syndrome? |
| Q36384704 | How do late terminations of pregnancy affect comparisons of stillbirth rates in Europe? Analyses of aggregated routine data from the Euro-Peristat Project. |
| Q42607477 | Impact of introduction of mid-trimester scan on pregnancy outcome of open spina bifida in The Netherlands. |
| Q33588817 | Influence of place of residence on indications for genetic amniocentesis in the Pomeranian region of Poland before and after introduction of the Prenatal Screening Program in 2008. |
| Q56777121 | Informed decision-making about the fetal anomaly scan: what knowledge is relevant? |
| Q53671303 | Informing on prenatal screening for Down syndrome prior to conception. An empirical and ethical perspective. |
| Q91638841 | Just choice: a Danielsian analysis of the aims and scope of prenatal screening for fetal abnormalities |
| Q43818586 | Late diagnosis of fetal central nervous system anomalies following a normal second trimester anatomy scan. |
| Q36316162 | Long term trends in prevalence of neural tube defects in Europe: population based study |
| Q57077332 | Major congenital anomalies in babies born with Down syndrome: A EUROCAT population-based registry study |
| Q52566924 | Maternal age and offspring developmental vulnerability at age five: A population-based cohort study of Australian children. |
| Q24234827 | Medical methods for mid-trimester termination of pregnancy |
| Q58045912 | Methods to estimate access to care and the effect of interventions on the outcomes of congenital disorders |
| Q38900558 | Mother's awareness and attitudes towards prenatal screening for Down syndrome in Muslim Moroccans |
| Q37611387 | Myoinositol: The Bridge (PONTI) to Reach a Healthy Pregnancy. |
| Q35206800 | Needs and challenges of daily life for people with Down syndrome residing in the city of Rome, Italy |
| Q48250916 | Older mothers and increased impact of prenatal screening: stable livebirth prevalence of trisomy 21 in the Netherlands for the period 2000-2013. |
| Q37850772 | Paper 1: The EUROCAT network--organization and processes |
| Q35874233 | Paper 2: EUROCAT public health indicators for congenital anomalies in Europe |
| Q36117899 | Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases |
| Q47821213 | Prenatal diagnosis and epidemiology of multicystic kidney dysplasia in Europe. |
| Q53698371 | Prenatal diagnostic services in three regional centers in Vietnam. |
| Q35399092 | Prenatal screening, diagnosis, and pregnancy management of fetal neural tube defects |
| Q84836506 | Prenatal testing for Down syndrome: comparison of screening practices in the UK and USA |
| Q36224175 | Prevalence, prenatal screening and neonatal features in children with Down syndrome: a registry-based national study |
| Q48217175 | Prevalence, timing of diagnosis and pregnancy outcome of abdominal wall defects after the introduction of a national prenatal screening program |
| Q35263555 | Prospective experience with contingent screening strategy for Down syndrome in Estonia |
| Q35304082 | Rapid aneuploidy detection or karyotyping? Ethical reflection |
| Q34576289 | Rapid testing versus karyotyping in Down's syndrome screening: cost-effectiveness and detection of clinically significant chromosome abnormalities |
| Q35899367 | Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe |
| Q36045923 | Rates of prenatal screening across health care regions in Ontario, Canada: a retrospective cohort study |
| Q55342477 | Reasons for non-participation in malformation scans in Denmark: a cohort study. |
| Q36264202 | Risk estimates of recurrent congenital anomalies in the UK: a population-based register study |
| Q34514946 | Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy |
| Q90131667 | Should pregnant women be charged for non-invasive prenatal screening? Implications for reproductive autonomy and equal access |
| Q44686155 | Survey of second-trimester maternal serum screening in Japan |
| Q57316884 | THE PRENATAL MANAGEMENT OF NEURAL TUBE DEFECTS: TIME FOR A RE-APPRAISAL |
| Q58224291 | Termination for fetal anomaly: Are women in England given a choice of method? |
| Q48236801 | Termination of pregnancy after prenatal diagnosis of spina bifida: a German perspective. |
| Q40681236 | Termination of pregnancy for fetal abnormalities: main arguments and a decision-tree model |
| Q36240936 | The impact of national prenatal screening on the time of diagnosis and outcome of pregnancies affected with common trisomies, a cohort study in the Northern Netherlands |
| Q37233919 | The importance of rapid aneuploidy screening and prenatal diagnosis in the detection of numerical chromosomal abnormalities |
| Q37725576 | Time trends in the prevalence and epidemiological characteristics of neural tube defects in Liaoning Province, China, 2006-2015: A population-based study |
| Q64236154 | Trends in resource use and effectiveness of ultrasound detection of fetal structural anomalies in France: a multiple registry-based study |
| Q46013175 | Trends in the utilization of invasive prenatal diagnosis in The Netherlands during 2000-2009. |
| Q36466446 | Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening |
| Q41703463 | Ultrasound screening for fetal growth restriction at 36 vs 32 weeks' gestation: a randomized trial (ROUTE). |
| Q58106651 | Unjustified: The Imbalance of Information and Funding With Noninvasive Prenatal Screening |
| Q45752972 | Women and their partners' preferences for Down's syndrome screening tests: a discrete choice experiment. |
| Q46672166 | Women's decision making regarding choice of second trimester termination method for pregnancy complications |
| Q48829483 | Women's experience of termination of pregnancy for fetal anomaly: effects of socio-political evolutions in France. |
| Q59216296 | Women’s experience of care when undergoing termination of pregnancy for fetal anomaly in England |
| Q83179009 | [Progress in pediatric cardiology, congenital heart disease in adults, and heart surgery for congenital heart disease] |
Search more.